New Ray Medicine International Holding Ltd. announced a share consolidation, whereby every ten issued and unissued shares of par value HK$0.05 each will be consolidated into one share of par value HK$0.50. Following this, the total number of consolidated shares will be rounded down to eliminate any fractions. Additionally, the par value of each issued consolidated share will be reduced from HK$0.50 to HK$0.01. This move aims to streamline the company's share structure.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.